🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchEfinopegdutide — what worked for you? Page 2

Efinopegdutide — what worked for you?

marcus_mpls Sun, Aug 4, 2024 at 3:39 PM 14 replies 2,111 viewsPage 2 of 3
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Aug 4, 2024 at 11:41 PM#6
labquiet_amy said:
Read four things before the headline number.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

That is the short version; the long version is somebody else's post.

50 20VendorMark, COA_Karl, MikeFit_NJ and 47 others
Reply Quote Save Share Report
anders_CPH
Senior Member
1,567
7,234
Feb 2024
Copenhagen, DK
Aug 5, 2024 at 2:51 AM#7
marcus_mpls said:
My own curve sits about four points below the published mean and I spent two months assuming that meant something was wrong with me or with my…
marcus_mpls said:
...regarding the trial evidence...

I think this is an underappreciated point. To expand on it with some data:

A recent meta-analysis of 15 RCTs (n=12,300) found that the trial evidence was associated with a clinically meaningful effect size across diverse patient populations[1].

The NNT was 12, which is comparable to antihypertensives for stroke reduction. That's a strong clinical argument for this approach.

Last edited: Aug 5, 2024 at 6:51 AM
49 19MariaRD, AussieAnna, BethLabQueen and 46 others
Reply Quote Save Share Report
sophie_paris
Member
212
890
Nov 2024
Paris, FR
Aug 5, 2024 at 6:01 AM#8
DataDave said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to:

  1. Point estimate (HR/RR/OR) — center of the diamond
  2. Confidence interval width — precision of the estimate
  3. I² statistic — heterogeneity across studies
  4. Individual study weights — are results driven by one large trial?
  5. Prediction interval — range of plausible true effects in future settings

The the trial evidence meta-analysis shows a pooled RR of 0.72 (95% CI 0.72-0.87), I²=45%. This is a robust and consistent effect.

Last edited: Aug 5, 2024 at 11:01 AM
48 18MariaRD, AussieAnna, BethLabQueen and 45 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Aug 5, 2024 at 9:11 AM#9

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

47 17rick_sfbay, maria_elpaso, anders_CPH and 44 others
Reply Quote Save Share Report
marcus_mpls
Member
234
1,123
Nov 2024
Minneapolis, MN
Aug 6, 2024 at 12:25 AM#10

OP back with an update, since a thread like this is useless without one.

Follow-up: I read the paper rather than the summary and the qualifier I was missing was in the second paragraph of the results.

Last edited: Aug 6, 2024 at 5:25 AM
21 19mona_PHX, andrew_nyc, Dr.EndoEP and 18 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register